Advertisement

Index by Author

June 2000; 49 (6)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Afek, A

    • Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes June 2000 49:1064-1069; doi:10.2337/diabetes.49.6.1064

  2. Akerblom, H K

    • Cow's milk consumption, HLA-DQB1 genotype, and type 1 diabetes: a nested case-control study of siblings of children with diabetes. Childhood diabetes in Finland study group. Diabetes June 2000 49:912-917; doi:10.2337/diabetes.49.6.912

  3. Almgren, P

    • Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes June 2000 49:975-980; doi:10.2337/diabetes.49.6.975

  4. Aro, A

    • Cow's milk consumption, HLA-DQB1 genotype, and type 1 diabetes: a nested case-control study of siblings of children with diabetes. Childhood diabetes in Finland study group. Diabetes June 2000 49:912-917; doi:10.2337/diabetes.49.6.912

  5. Aynsley-Green, A

    • Sulfonylurea receptor 1 and Kir6.2 expression in the novel human insulin-secreting cell line NES2Y. Diabetes June 2000 49:953-960; doi:10.2337/diabetes.49.6.953

B

  1. Badr, G A

    • Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels. Diabetes June 2000 49:1016-1021; doi:10.2337/diabetes.49.6.1016

  2. Bao, W

    • Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: the Bogalusa Heart Study. Diabetes June 2000 49:1042-1048; doi:10.2337/diabetes.49.6.1042

  3. Barnes, P D

    • Sulfonylurea receptor 1 and Kir6.2 expression in the novel human insulin-secreting cell line NES2Y. Diabetes June 2000 49:953-960; doi:10.2337/diabetes.49.6.953

  4. Beck, A

    • Serine residues 1177/78/82 of the insulin receptor are required for substrate phosphorylation but not autophosphorylation. Diabetes June 2000 49:889-895; doi:10.2337/diabetes.49.6.889

  5. Begum, S

    • Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: the Bogalusa Heart Study. Diabetes June 2000 49:1042-1048; doi:10.2337/diabetes.49.6.1042

  6. Bell, G I

    • Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4alpha/MODY1 gene. Diabetes June 2000 49:961-968; doi:10.2337/diabetes.49.6.961

  7. Bennett, P H

    • Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes June 2000 49:1049-1056; doi:10.2337/diabetes.49.6.1049

  8. Berenson, G S

    • Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: the Bogalusa Heart Study. Diabetes June 2000 49:1042-1048; doi:10.2337/diabetes.49.6.1042

  9. Bonadonna, R C

    • Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes June 2000 49:926-935; doi:10.2337/diabetes.49.6.926

  10. Bonifacio, E

    • Exposure to exogenous insulin promotes IgG1 and the T-helper 2-associated IgG4 responses to insulin but not to other islet autoantigens. Diabetes June 2000 49:918-925; doi:10.2337/diabetes.49.6.918

  11. Bonora, E

    • Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes June 2000 49:926-935; doi:10.2337/diabetes.49.6.926

  12. Bossenmaier, B

    • Serine residues 1177/78/82 of the insulin receptor are required for substrate phosphorylation but not autophosphorylation. Diabetes June 2000 49:889-895; doi:10.2337/diabetes.49.6.889

  13. Breslow, G D

    • Expression and role of laminin-1 in mouse pancreatic organogenesis. Diabetes June 2000 49:936-944; doi:10.2337/diabetes.49.6.936

  14. Buse, M G

    • High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes. Diabetes June 2000 49:981-991; doi:10.2337/diabetes.49.6.981

C

  1. Cao, X

    • Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes June 2000 49:1006-1015; doi:10.2337/diabetes.49.6.1006

  2. Caputo, M

    • Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes June 2000 49:926-935; doi:10.2337/diabetes.49.6.926

  3. Carlsson, M

    • Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes June 2000 49:975-980; doi:10.2337/diabetes.49.6.975

  4. Caruso, B

    • Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes June 2000 49:926-935; doi:10.2337/diabetes.49.6.926

  5. Chen, W

    • Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: the Bogalusa Heart Study. Diabetes June 2000 49:1042-1048; doi:10.2337/diabetes.49.6.1042

  6. Clore, J N

    • Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes. Diabetes June 2000 49:969-974; doi:10.2337/diabetes.49.6.969

  7. Cosgrove, K E

    • Sulfonylurea receptor 1 and Kir6.2 expression in the novel human insulin-secreting cell line NES2Y. Diabetes June 2000 49:953-960; doi:10.2337/diabetes.49.6.953

  8. Cretti, A

    • Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes June 2000 49:926-935; doi:10.2337/diabetes.49.6.926

  9. Crisera, C A

    • Expression and role of laminin-1 in mouse pancreatic organogenesis. Diabetes June 2000 49:936-944; doi:10.2337/diabetes.49.6.936

D

  1. D'Souza, E

    • Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4alpha/MODY1 gene. Diabetes June 2000 49:961-968; doi:10.2337/diabetes.49.6.961

  2. Daniels, M C

    • Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes June 2000 49:926-935; doi:10.2337/diabetes.49.6.926

  3. Del Prato, S

    • Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes June 2000 49:926-935; doi:10.2337/diabetes.49.6.926

  4. Docherty, K

    • Sulfonylurea receptor 1 and Kir6.2 expression in the novel human insulin-secreting cell line NES2Y. Diabetes June 2000 49:953-960; doi:10.2337/diabetes.49.6.953

  5. Dunne, M J

    • Sulfonylurea receptor 1 and Kir6.2 expression in the novel human insulin-secreting cell line NES2Y. Diabetes June 2000 49:953-960; doi:10.2337/diabetes.49.6.953

E

  1. Elkasabany, A

    • Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: the Bogalusa Heart Study. Diabetes June 2000 49:1042-1048; doi:10.2337/diabetes.49.6.1042

F

  1. Fajans, S S

    • Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4alpha/MODY1 gene. Diabetes June 2000 49:961-968; doi:10.2337/diabetes.49.6.961

  2. Fogarty, D G

    • Segregation analysis of urinary albumin excretion in families with type 2 diabetes. Diabetes June 2000 49:1057-1063; doi:10.2337/diabetes.49.6.1057

  3. Fried, S K

    • Adipocyte metabolism in adipocyte fatty acid binding protein knockout mice (aP2-/-) after short-term high-fat feeding: functional compensation by the keratinocyte [correction of keritinocyte] fatty acid binding protein. Diabetes June 2000 49:904-911; doi:10.2337/diabetes.49.6.904

  4. Füchtenbusch, M

    • Exposure to exogenous insulin promotes IgG1 and the T-helper 2-associated IgG4 responses to insulin but not to other islet autoantigens. Diabetes June 2000 49:918-925; doi:10.2337/diabetes.49.6.918

  5. Fukasawa, T

    • Synergism of protein kinase A, protein kinase C, and myosin light-chain kinase in the secretory cascade of the pancreatic beta-cell. Diabetes June 2000 49:945-952; doi:10.2337/diabetes.49.6.945

G

  1. George, J

    • Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes June 2000 49:1064-1069; doi:10.2337/diabetes.49.6.1064

  2. Giaccari, A

    • Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes June 2000 49:926-935; doi:10.2337/diabetes.49.6.926

  3. Gittes, G K

    • Expression and role of laminin-1 in mouse pancreatic organogenesis. Diabetes June 2000 49:936-944; doi:10.2337/diabetes.49.6.936

  4. Goldberg, I

    • Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes June 2000 49:1064-1069; doi:10.2337/diabetes.49.6.1064

  5. Greene, D A

    • Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes June 2000 49:1006-1015; doi:10.2337/diabetes.49.6.1006

  6. Groop, L C

    • Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes June 2000 49:975-980; doi:10.2337/diabetes.49.6.975

H

  1. Haneda, M

    • Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats. Diabetes June 2000 49:1022-1032; doi:10.2337/diabetes.49.6.1022

  2. Hanna, L S

    • Segregation analysis of urinary albumin excretion in families with type 2 diabetes. Diabetes June 2000 49:1057-1063; doi:10.2337/diabetes.49.6.1057

  3. Hanson, R L

    • Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes June 2000 49:1049-1056; doi:10.2337/diabetes.49.6.1049

  4. Harats, D

    • Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes June 2000 49:1064-1069; doi:10.2337/diabetes.49.6.1064

  5. Hardie, D G

    • 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes June 2000 49:896-903; doi:10.2337/diabetes.49.6.896

  6. Häring, H U

    • Serine residues 1177/78/82 of the insulin receptor are required for substrate phosphorylation but not autophosphorylation. Diabetes June 2000 49:889-895; doi:10.2337/diabetes.49.6.889
    • Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity. Diabetes June 2000 49:992-998; doi:10.2337/diabetes.49.6.992

  7. Herman, W H

    • Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4alpha/MODY1 gene. Diabetes June 2000 49:961-968; doi:10.2337/diabetes.49.6.961

  8. Hidaka, H

    • Synergism of protein kinase A, protein kinase C, and myosin light-chain kinase in the secretory cascade of the pancreatic beta-cell. Diabetes June 2000 49:945-952; doi:10.2337/diabetes.49.6.945

  9. Hyppönen, E

    • Cow's milk consumption, HLA-DQB1 genotype, and type 1 diabetes: a nested case-control study of siblings of children with diabetes. Childhood diabetes in Finland study group. Diabetes June 2000 49:912-917; doi:10.2337/diabetes.49.6.912

I

  1. Ilag, L L

    • Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4alpha/MODY1 gene. Diabetes June 2000 49:961-968; doi:10.2337/diabetes.49.6.961

  2. Ilonen, J

    • Cow's milk consumption, HLA-DQB1 genotype, and type 1 diabetes: a nested case-control study of siblings of children with diabetes. Childhood diabetes in Finland study group. Diabetes June 2000 49:912-917; doi:10.2337/diabetes.49.6.912

  3. Imperatore, G

    • Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes June 2000 49:1049-1056; doi:10.2337/diabetes.49.6.1049

  4. Ismail-Beigi, F

    • Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels. Diabetes June 2000 49:1016-1021; doi:10.2337/diabetes.49.6.1016

  5. Isomaa, B

    • Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes June 2000 49:975-980; doi:10.2337/diabetes.49.6.975

  6. Isshiki, K

    • Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats. Diabetes June 2000 49:1022-1032; doi:10.2337/diabetes.49.6.1022

J

  1. James, R F

    • Sulfonylurea receptor 1 and Kir6.2 expression in the novel human insulin-secreting cell line NES2Y. Diabetes June 2000 49:953-960; doi:10.2337/diabetes.49.6.953

  2. Janakovic, Z

    • Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes June 2000 49:1064-1069; doi:10.2337/diabetes.49.6.1064

  3. Jonassen, I

    • Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes June 2000 49:999-1005; doi:10.2337/diabetes.49.6.999

K

  1. Kadison, A S

    • Expression and role of laminin-1 in mouse pancreatic organogenesis. Diabetes June 2000 49:936-944; doi:10.2337/diabetes.49.6.936

  2. Kausch, C

    • Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity. Diabetes June 2000 49:992-998; doi:10.2337/diabetes.49.6.992

  3. Kellerer, M

    • Serine residues 1177/78/82 of the insulin receptor are required for substrate phosphorylation but not autophosphorylation. Diabetes June 2000 49:889-895; doi:10.2337/diabetes.49.6.889

  4. Keren, G

    • Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes June 2000 49:1064-1069; doi:10.2337/diabetes.49.6.1064

  5. Keren, P

    • Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes June 2000 49:1064-1069; doi:10.2337/diabetes.49.6.1064

  6. Kern, T S

    • Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels. Diabetes June 2000 49:1016-1021; doi:10.2337/diabetes.49.6.1016

  7. Kikkawa, R

    • Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats. Diabetes June 2000 49:1022-1032; doi:10.2337/diabetes.49.6.1022

  8. Klein, H

    • Serine residues 1177/78/82 of the insulin receptor are required for substrate phosphorylation but not autophosphorylation. Diabetes June 2000 49:889-895; doi:10.2337/diabetes.49.6.889

  9. Klein, H H

    • Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity. Diabetes June 2000 49:992-998; doi:10.2337/diabetes.49.6.992

  10. Klein, R L

    • Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes. Diabetes June 2000 49:1033-1041; doi:10.2337/diabetes.49.6.1033

  11. Knip, M

    • Cow's milk consumption, HLA-DQB1 genotype, and type 1 diabetes: a nested case-control study of siblings of children with diabetes. Childhood diabetes in Finland study group. Diabetes June 2000 49:912-917; doi:10.2337/diabetes.49.6.912

  12. Knowler, W C

    • Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes June 2000 49:1049-1056; doi:10.2337/diabetes.49.6.1049

  13. Kobes, S

    • Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes June 2000 49:1049-1056; doi:10.2337/diabetes.49.6.1049

  14. Kodukula, S

    • Adipocyte metabolism in adipocyte fatty acid binding protein knockout mice (aP2-/-) after short-term high-fat feeding: functional compensation by the keratinocyte [correction of keritinocyte] fatty acid binding protein. Diabetes June 2000 49:904-911; doi:10.2337/diabetes.49.6.904

  15. Kopolovic, J

    • Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes June 2000 49:1064-1069; doi:10.2337/diabetes.49.6.1064

  16. Koya, D

    • Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats. Diabetes June 2000 49:1022-1032; doi:10.2337/diabetes.49.6.1022

  17. Kredel, K

    • Exposure to exogenous insulin promotes IgG1 and the T-helper 2-associated IgG4 responses to insulin but not to other islet autoantigens. Diabetes June 2000 49:918-925; doi:10.2337/diabetes.49.6.918

  18. Kristensen, C

    • Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes June 2000 49:999-1005; doi:10.2337/diabetes.49.6.999

  19. Krolewski, A S

    • Segregation analysis of urinary albumin excretion in families with type 2 diabetes. Diabetes June 2000 49:1057-1063; doi:10.2337/diabetes.49.6.1057

  20. Krützfeldt, J

    • Serine residues 1177/78/82 of the insulin receptor are required for substrate phosphorylation but not autophosphorylation. Diabetes June 2000 49:889-895; doi:10.2337/diabetes.49.6.889
    • Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity. Diabetes June 2000 49:992-998; doi:10.2337/diabetes.49.6.992

  21. Kurtzhals, P

    • Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes June 2000 49:999-1005; doi:10.2337/diabetes.49.6.999

L

  1. Läärä, E

    • Cow's milk consumption, HLA-DQB1 genotype, and type 1 diabetes: a nested case-control study of siblings of children with diabetes. Childhood diabetes in Finland study group. Diabetes June 2000 49:912-917; doi:10.2337/diabetes.49.6.912

  2. Lammers, R

    • Serine residues 1177/78/82 of the insulin receptor are required for substrate phosphorylation but not autophosphorylation. Diabetes June 2000 49:889-895; doi:10.2337/diabetes.49.6.889

  3. Lehmann, R

    • Serine residues 1177/78/82 of the insulin receptor are required for substrate phosphorylation but not autophosphorylation. Diabetes June 2000 49:889-895; doi:10.2337/diabetes.49.6.889

  4. Levkovitz, H

    • Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes June 2000 49:1064-1069; doi:10.2337/diabetes.49.6.1064

  5. Lindley, K J

    • Sulfonylurea receptor 1 and Kir6.2 expression in the novel human insulin-secreting cell line NES2Y. Diabetes June 2000 49:953-960; doi:10.2337/diabetes.49.6.953

  6. Lochhead, P A

    • 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes June 2000 49:896-903; doi:10.2337/diabetes.49.6.896

  7. Longaker, M T

    • Expression and role of laminin-1 in mouse pancreatic organogenesis. Diabetes June 2000 49:936-944; doi:10.2337/diabetes.49.6.936

  8. Lopes-Virella, M F

    • Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes. Diabetes June 2000 49:1033-1041; doi:10.2337/diabetes.49.6.1033

M

  1. Macfarlane, W M

    • Sulfonylurea receptor 1 and Kir6.2 expression in the novel human insulin-secreting cell line NES2Y. Diabetes June 2000 49:953-960; doi:10.2337/diabetes.49.6.953

  2. Maeda, S

    • Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats. Diabetes June 2000 49:1022-1032; doi:10.2337/diabetes.49.6.1022

  3. Maldonado, T S

    • Expression and role of laminin-1 in mouse pancreatic organogenesis. Diabetes June 2000 49:936-944; doi:10.2337/diabetes.49.6.936

  4. McClain, D

    • Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes June 2000 49:926-935; doi:10.2337/diabetes.49.6.926

  5. Mironova, M A

    • Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes. Diabetes June 2000 49:1033-1041; doi:10.2337/diabetes.49.6.1033

  6. Monauni, T

    • Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes June 2000 49:926-935; doi:10.2337/diabetes.49.6.926

  7. Montague, C T

    • The perils of portliness: causes and consequences of visceral adiposity. Diabetes June 2000 49:883-888; doi:10.2337/diabetes.49.6.883

  8. Muggeo, M

    • Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes June 2000 49:926-935; doi:10.2337/diabetes.49.6.926

N

  1. Nelson, B A

    • High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes. Diabetes June 2000 49:981-991; doi:10.2337/diabetes.49.6.981

  2. Niki, I

    • Synergism of protein kinase A, protein kinase C, and myosin light-chain kinase in the secretory cascade of the pancreatic beta-cell. Diabetes June 2000 49:945-952; doi:10.2337/diabetes.49.6.945

  3. Niwa, T

    • Synergism of protein kinase A, protein kinase C, and myosin light-chain kinase in the secretory cascade of the pancreatic beta-cell. Diabetes June 2000 49:945-952; doi:10.2337/diabetes.49.6.945

O

  1. O'Brien, R E

    • Sulfonylurea receptor 1 and Kir6.2 expression in the novel human insulin-secreting cell line NES2Y. Diabetes June 2000 49:953-960; doi:10.2337/diabetes.49.6.953

  2. O'Rahilly, S

    • The perils of portliness: causes and consequences of visceral adiposity. Diabetes June 2000 49:883-888; doi:10.2337/diabetes.49.6.883

  3. Obrosova, I

    • Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes June 2000 49:1006-1015; doi:10.2337/diabetes.49.6.1006

P

  1. Pettitt, D J

    • Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes June 2000 49:1049-1056; doi:10.2337/diabetes.49.6.1049

R

  1. Räsänen, L

    • Cow's milk consumption, HLA-DQB1 genotype, and type 1 diabetes: a nested case-control study of siblings of children with diabetes. Childhood diabetes in Finland study group. Diabetes June 2000 49:912-917; doi:10.2337/diabetes.49.6.912

  2. Reijonen, H

    • Cow's milk consumption, HLA-DQB1 genotype, and type 1 diabetes: a nested case-control study of siblings of children with diabetes. Childhood diabetes in Finland study group. Diabetes June 2000 49:912-917; doi:10.2337/diabetes.49.6.912

  3. Rett, K

    • Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity. Diabetes June 2000 49:992-998; doi:10.2337/diabetes.49.6.992

  4. Rich, S S

    • Segregation analysis of urinary albumin excretion in families with type 2 diabetes. Diabetes June 2000 49:1057-1063; doi:10.2337/diabetes.49.6.1057

  5. Robinson, K A

    • High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes. Diabetes June 2000 49:981-991; doi:10.2337/diabetes.49.6.981

S

  1. Salt, I P

    • 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes June 2000 49:896-903; doi:10.2337/diabetes.49.6.896

  2. Sasaki, Y

    • Synergism of protein kinase A, protein kinase C, and myosin light-chain kinase in the secretory cascade of the pancreatic beta-cell. Diabetes June 2000 49:945-952; doi:10.2337/diabetes.49.6.945

  3. Schäffer, L

    • Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes June 2000 49:999-1005; doi:10.2337/diabetes.49.6.999

  4. Schmid, C

    • Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes June 2000 49:999-1005; doi:10.2337/diabetes.49.6.999

  5. Schnell, O

    • Exposure to exogenous insulin promotes IgG1 and the T-helper 2-associated IgG4 responses to insulin but not to other islet autoantigens. Diabetes June 2000 49:918-925; doi:10.2337/diabetes.49.6.918

  6. Senda, T

    • Synergism of protein kinase A, protein kinase C, and myosin light-chain kinase in the secretory cascade of the pancreatic beta-cell. Diabetes June 2000 49:945-952; doi:10.2337/diabetes.49.6.945

  7. Shaish, A

    • Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-deficient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes June 2000 49:1064-1069; doi:10.2337/diabetes.49.6.1064

  8. Shaughnessy, S

    • Adipocyte metabolism in adipocyte fatty acid binding protein knockout mice (aP2-/-) after short-term high-fat feeding: functional compensation by the keratinocyte [correction of keritinocyte] fatty acid binding protein. Diabetes June 2000 49:904-911; doi:10.2337/diabetes.49.6.904

  9. Shepherd, R M

    • Sulfonylurea receptor 1 and Kir6.2 expression in the novel human insulin-secreting cell line NES2Y. Diabetes June 2000 49:953-960; doi:10.2337/diabetes.49.6.953

  10. Smith, E R

    • Adipocyte metabolism in adipocyte fatty acid binding protein knockout mice (aP2-/-) after short-term high-fat feeding: functional compensation by the keratinocyte [correction of keritinocyte] fatty acid binding protein. Diabetes June 2000 49:904-911; doi:10.2337/diabetes.49.6.904

  11. Srinivasan, S R

    • Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: the Bogalusa Heart Study. Diabetes June 2000 49:1042-1048; doi:10.2337/diabetes.49.6.1042

  12. Stevens, M J

    • Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes June 2000 49:1006-1015; doi:10.2337/diabetes.49.6.1006

  13. Stillman, J

    • Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes. Diabetes June 2000 49:969-974; doi:10.2337/diabetes.49.6.969

  14. Storch, J

    • Adipocyte metabolism in adipocyte fatty acid binding protein knockout mice (aP2-/-) after short-term high-fat feeding: functional compensation by the keratinocyte [correction of keritinocyte] fatty acid binding protein. Diabetes June 2000 49:904-911; doi:10.2337/diabetes.49.6.904

  15. Stoyanov, B

    • Serine residues 1177/78/82 of the insulin receptor are required for substrate phosphorylation but not autophosphorylation. Diabetes June 2000 49:889-895; doi:10.2337/diabetes.49.6.889

  16. Strack, V

    • Serine residues 1177/78/82 of the insulin receptor are required for substrate phosphorylation but not autophosphorylation. Diabetes June 2000 49:889-895; doi:10.2337/diabetes.49.6.889

  17. Stumvoll, M

    • Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity. Diabetes June 2000 49:992-998; doi:10.2337/diabetes.49.6.992

  18. Sugerman, H

    • Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes. Diabetes June 2000 49:969-974; doi:10.2337/diabetes.49.6.969

  19. Sugimoto, T

    • Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats. Diabetes June 2000 49:1022-1032; doi:10.2337/diabetes.49.6.1022

  20. Sutherland, C

    • 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes June 2000 49:896-903; doi:10.2337/diabetes.49.6.896

  21. Sørensen, A

    • Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes June 2000 49:999-1005; doi:10.2337/diabetes.49.6.999

T

  1. Tabaei, B P

    • Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4alpha/MODY1 gene. Diabetes June 2000 49:961-968; doi:10.2337/diabetes.49.6.961

  2. Tang, J

    • Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels. Diabetes June 2000 49:1016-1021; doi:10.2337/diabetes.49.6.1016

  3. Targher, G

    • Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes June 2000 49:926-935; doi:10.2337/diabetes.49.6.926

  4. Taskinen, M R

    • Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes June 2000 49:975-980; doi:10.2337/diabetes.49.6.975

  5. Tripathy, D

    • Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes June 2000 49:975-980; doi:10.2337/diabetes.49.6.975

  6. Trüb, T

    • Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes June 2000 49:999-1005; doi:10.2337/diabetes.49.6.999

  7. Tuomi, T

    • Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes June 2000 49:975-980; doi:10.2337/diabetes.49.6.975

U

  1. Ullrich, A

    • Serine residues 1177/78/82 of the insulin receptor are required for substrate phosphorylation but not autophosphorylation. Diabetes June 2000 49:889-895; doi:10.2337/diabetes.49.6.889

V

  1. Van Huysen, C

    • Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes June 2000 49:1006-1015; doi:10.2337/diabetes.49.6.1006

  2. Virella, G T

    • Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes. Diabetes June 2000 49:1033-1041; doi:10.2337/diabetes.49.6.1033

  3. Virtanen, S M

    • Cow's milk consumption, HLA-DQB1 genotype, and type 1 diabetes: a nested case-control study of siblings of children with diabetes. Childhood diabetes in Finland study group. Diabetes June 2000 49:912-917; doi:10.2337/diabetes.49.6.912

  4. Volk, A

    • Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity. Diabetes June 2000 49:992-998; doi:10.2337/diabetes.49.6.992

W

  1. Walker, K S

    • 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes June 2000 49:896-903; doi:10.2337/diabetes.49.6.896

  2. Wantman, M

    • Segregation analysis of urinary albumin excretion in families with type 2 diabetes. Diabetes June 2000 49:1057-1063; doi:10.2337/diabetes.49.6.1057

  3. Warram, J H

    • Segregation analysis of urinary albumin excretion in families with type 2 diabetes. Diabetes June 2000 49:1057-1063; doi:10.2337/diabetes.49.6.1057

Y

  1. Yu, W

    • Synergism of protein kinase A, protein kinase C, and myosin light-chain kinase in the secretory cascade of the pancreatic beta-cell. Diabetes June 2000 49:945-952; doi:10.2337/diabetes.49.6.945

Z

  1. Zawacki, C M

    • Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4alpha/MODY1 gene. Diabetes June 2000 49:961-968; doi:10.2337/diabetes.49.6.961

  2. Zenti, M G

    • Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes June 2000 49:926-935; doi:10.2337/diabetes.49.6.926

  3. Ziegler, A G

    • Exposure to exogenous insulin promotes IgG1 and the T-helper 2-associated IgG4 responses to insulin but not to other islet autoantigens. Diabetes June 2000 49:918-925; doi:10.2337/diabetes.49.6.918

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement